Cryptococcus protein Cda1 triggers lethal brain infections

Scientists have discovered how a common fungus turns deadly, switching from a silent lung infection to a fatal brain disease in vulnerable patients. The breakthrough reveals why Cryptococcus, a yeast-like microbe found in soil and bird droppings, suddenly becomes lethal in people with weakened immune systems. Until now, researchers knew the fungus could reactivate and cause meningitis, but not how it made that deadly shift.

Cryptococcus typically enters the body through the lungs. In healthy people, the immune system traps it there, keeping it dormant for life. But in those undergoing chemotherapy, organ transplant recipients, people with HIV, or patients taking drugs that suppress the immune system for autoimmune diseases, the fungus can escape and travel to the brain. Once there, it causes cryptococcal meningitis, a disease that kills nearly 200,000 people worldwide each year. The new research, published in *Nature Microbiology*, shows how the fungus changes its behavior under immune pressure, switching from a harmless hibernation to an aggressive, fast-growing state.

The study found that when immune cells called macrophages try to contain the fungus, Cryptococcus responds by altering its metabolism. It starts producing more of a molecule called GXM, which forms a thick capsule around the fungus, protecting it from attack. At the same time, it speeds up its growth rate, turning a quiet infection into a rapidly spreading disease. Researchers analyzed samples from patients and lab experiments to trace this transformation. They also identified a key protein, called Cda1, that triggers the shift in behavior. Blocking this protein could stop the fungus from waking up and causing meningitis.

The discovery opens new avenues for treatment. Current drugs like fluconazole and amphotericin B can treat cryptococcal meningitis, but they are toxic and often fail. The research suggests targeting the Cda1 protein could prevent the fungus from reactivating in the first place. Scientists are now testing drugs that inhibit this protein in animal models. If successful, these could be used alongside existing treatments to reduce deaths from this deadly disease. The findings also highlight the need for better monitoring of Cryptococcus in high-risk patients, as early detection could save lives.